Candel Therapeutics, Inc.CADLNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-0.41
Operating CF/Share$-0.61
Free CF/Share$-0.61
Cash/Share$1.58
Book Value/Share$1.46
Tangible Book/Share$1.46
Equity/Share$1.46
Interest Debt/Share$0.13
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$326.10M
Enterprise Value$245.37M
P/E Ratio-14.33P/S Ratio0.00P/OCF Ratio-9.72
P/FCF Ratio-9.67
P/B Ratio4.07P/TB Ratio4.07
EV/Sales0.00EV/EBITDA-11.83
Graham Valuation
Graham Number--
Graham Net-Net$1.34
Profitability
Earnings Yield-6.98%FCF Yield-10.35%ROE-29.24%ROIC-46.55%Return on Tangible Assets-24.32%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.54%
CapEx/Revenue0.00%
CapEx/Depreciation0.20
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.08Debt/Assets0.07Debt/Market Cap0.02
Net Debt/EBITDA3.89
Current Ratio8.25Interest Coverage-37.20xIncome Quality1.47Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding440 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.83x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$80.12M
Working Capital$79.20M
Invested Capital$82.32M
Intangibles/Assets0.00%